FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy, and deals with application of angiogenin or its agonists for treating diseases mediated by impairment of myostatin activity. For this purpose an efficient amount of angiogenin or its agonist is introduced.
EFFECT: invention ensures growth and normalisation of muscular tissue function due to stimulation of differentiation of muscular cells in muscular tubes.
10 cl, 15 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MILK FRACTIONS ENRICHED WITH ANGIOGENINE | 2009 |
|
RU2538654C2 |
| USE OF TRYPTOPHAN METABOLITES FOR THE TREATMENT OF MUSCULAR ATROPHY | 2017 |
|
RU2806346C2 |
| NUETRALISING ANTIBODIES AGAINST GDF-8 AND THEIR APPLICATION | 2003 |
|
RU2360925C2 |
| APPLICATION OF GROWTH HORMONE FRAGMENTS | 2012 |
|
RU2639474C2 |
| ANTIBODY AGAINST IGF-I RECEPTOR | 2018 |
|
RU2785305C2 |
| STABILISED INSULIN-LIKE GROWTH FACTOR POLYPEPTIDES | 2007 |
|
RU2477287C2 |
| RECOMBINANT ANGIOGENIN IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2021 |
|
RU2784355C1 |
| RECOMBINANT ANGIOGENIN IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2022 |
|
RU2805144C1 |
| COMPOSITIONS CONTAINING NICOTINE AMIDRIBOSIDE AND UROLITIN | 2016 |
|
RU2751638C2 |
| APPLYING MYOSTATIC INHIBITORS (GDF8) IN COMBINATION WITH CORTICOSTEROIDS FOR TREATING NERVOUS-MUSCULAR DISEASES | 2004 |
|
RU2322261C2 |
